_version_ 1783469282186756096
author van der Kraaij, G.E.
Balak, D.M.W.
Busard, C.I.
van Cranenburgh, O.D.
Chung, Y.
Driessen, R.J.B.
de Groot, M.
de Jong, E.M.G.J.
Kemperman, P.M.J.H.
de Kort, W.J.A.
Karsch, S.A.
Lamberts, A.
Lecluse, L.L.A.
van Lümig, P.P.M.
Menting, S.P.
Prens, E.P.
van den Reek, J.M.P.A.
Seyger, M.M.B.
Thio, H.B.
Veldkamp, W.R.
Wakkee, M.
Nast, A.
Jacobs, A.
Rosumeck, S.
Spuls (Chair), P.I.
author_facet van der Kraaij, G.E.
Balak, D.M.W.
Busard, C.I.
van Cranenburgh, O.D.
Chung, Y.
Driessen, R.J.B.
de Groot, M.
de Jong, E.M.G.J.
Kemperman, P.M.J.H.
de Kort, W.J.A.
Karsch, S.A.
Lamberts, A.
Lecluse, L.L.A.
van Lümig, P.P.M.
Menting, S.P.
Prens, E.P.
van den Reek, J.M.P.A.
Seyger, M.M.B.
Thio, H.B.
Veldkamp, W.R.
Wakkee, M.
Nast, A.
Jacobs, A.
Rosumeck, S.
Spuls (Chair), P.I.
author_sort van der Kraaij, G.E.
collection PubMed
description Linked Comment: https://doi.org/10.1111/bjd.17390.
format Online
Article
Text
id pubmed-6849803
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-68498032019-11-15 Highlights of the updated Dutch evidence‐ and consensus‐based guideline on psoriasis 2017 van der Kraaij, G.E. Balak, D.M.W. Busard, C.I. van Cranenburgh, O.D. Chung, Y. Driessen, R.J.B. de Groot, M. de Jong, E.M.G.J. Kemperman, P.M.J.H. de Kort, W.J.A. Karsch, S.A. Lamberts, A. Lecluse, L.L.A. van Lümig, P.P.M. Menting, S.P. Prens, E.P. van den Reek, J.M.P.A. Seyger, M.M.B. Thio, H.B. Veldkamp, W.R. Wakkee, M. Nast, A. Jacobs, A. Rosumeck, S. Spuls (Chair), P.I. Br J Dermatol Evidence‐Based Dermatology Linked Comment: https://doi.org/10.1111/bjd.17390. John Wiley and Sons Inc. 2019-01-02 2019-01 /pmc/articles/PMC6849803/ /pubmed/30604536 http://dx.doi.org/10.1111/bjd.17198 Text en © 2018 The Authors. British Journal of Dermatology published by John Wiley & Sons Ltd on behalf of British Association of Dermatologists. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Evidence‐Based Dermatology
van der Kraaij, G.E.
Balak, D.M.W.
Busard, C.I.
van Cranenburgh, O.D.
Chung, Y.
Driessen, R.J.B.
de Groot, M.
de Jong, E.M.G.J.
Kemperman, P.M.J.H.
de Kort, W.J.A.
Karsch, S.A.
Lamberts, A.
Lecluse, L.L.A.
van Lümig, P.P.M.
Menting, S.P.
Prens, E.P.
van den Reek, J.M.P.A.
Seyger, M.M.B.
Thio, H.B.
Veldkamp, W.R.
Wakkee, M.
Nast, A.
Jacobs, A.
Rosumeck, S.
Spuls (Chair), P.I.
Highlights of the updated Dutch evidence‐ and consensus‐based guideline on psoriasis 2017
title Highlights of the updated Dutch evidence‐ and consensus‐based guideline on psoriasis 2017
title_full Highlights of the updated Dutch evidence‐ and consensus‐based guideline on psoriasis 2017
title_fullStr Highlights of the updated Dutch evidence‐ and consensus‐based guideline on psoriasis 2017
title_full_unstemmed Highlights of the updated Dutch evidence‐ and consensus‐based guideline on psoriasis 2017
title_short Highlights of the updated Dutch evidence‐ and consensus‐based guideline on psoriasis 2017
title_sort highlights of the updated dutch evidence‐ and consensus‐based guideline on psoriasis 2017
topic Evidence‐Based Dermatology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6849803/
https://www.ncbi.nlm.nih.gov/pubmed/30604536
http://dx.doi.org/10.1111/bjd.17198
work_keys_str_mv AT vanderkraaijge highlightsoftheupdateddutchevidenceandconsensusbasedguidelineonpsoriasis2017
AT balakdmw highlightsoftheupdateddutchevidenceandconsensusbasedguidelineonpsoriasis2017
AT busardci highlightsoftheupdateddutchevidenceandconsensusbasedguidelineonpsoriasis2017
AT vancranenburghod highlightsoftheupdateddutchevidenceandconsensusbasedguidelineonpsoriasis2017
AT chungy highlightsoftheupdateddutchevidenceandconsensusbasedguidelineonpsoriasis2017
AT driessenrjb highlightsoftheupdateddutchevidenceandconsensusbasedguidelineonpsoriasis2017
AT degrootm highlightsoftheupdateddutchevidenceandconsensusbasedguidelineonpsoriasis2017
AT dejongemgj highlightsoftheupdateddutchevidenceandconsensusbasedguidelineonpsoriasis2017
AT kempermanpmjh highlightsoftheupdateddutchevidenceandconsensusbasedguidelineonpsoriasis2017
AT dekortwja highlightsoftheupdateddutchevidenceandconsensusbasedguidelineonpsoriasis2017
AT karschsa highlightsoftheupdateddutchevidenceandconsensusbasedguidelineonpsoriasis2017
AT lambertsa highlightsoftheupdateddutchevidenceandconsensusbasedguidelineonpsoriasis2017
AT leclusella highlightsoftheupdateddutchevidenceandconsensusbasedguidelineonpsoriasis2017
AT vanlumigppm highlightsoftheupdateddutchevidenceandconsensusbasedguidelineonpsoriasis2017
AT mentingsp highlightsoftheupdateddutchevidenceandconsensusbasedguidelineonpsoriasis2017
AT prensep highlightsoftheupdateddutchevidenceandconsensusbasedguidelineonpsoriasis2017
AT vandenreekjmpa highlightsoftheupdateddutchevidenceandconsensusbasedguidelineonpsoriasis2017
AT seygermmb highlightsoftheupdateddutchevidenceandconsensusbasedguidelineonpsoriasis2017
AT thiohb highlightsoftheupdateddutchevidenceandconsensusbasedguidelineonpsoriasis2017
AT veldkampwr highlightsoftheupdateddutchevidenceandconsensusbasedguidelineonpsoriasis2017
AT wakkeem highlightsoftheupdateddutchevidenceandconsensusbasedguidelineonpsoriasis2017
AT nasta highlightsoftheupdateddutchevidenceandconsensusbasedguidelineonpsoriasis2017
AT jacobsa highlightsoftheupdateddutchevidenceandconsensusbasedguidelineonpsoriasis2017
AT rosumecks highlightsoftheupdateddutchevidenceandconsensusbasedguidelineonpsoriasis2017
AT spulschairpi highlightsoftheupdateddutchevidenceandconsensusbasedguidelineonpsoriasis2017